Celldex Therapeutics
CLDX
#4699
Rank
S$2.51 B
Marketcap
S$37.82
Share price
-1.82%
Change (1 day)
39.70%
Change (1 year)

Market capitalization of Celldex Therapeutics (CLDX)

Market cap: S$2.51 Billion

As of March 2026 Celldex Therapeutics has a market cap of S$2.51 Billion. This makes Celldex Therapeutics the world's 4699th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Celldex Therapeutics from 1996 to 2026

End of year Market Cap

Year Marketcap Change
2026S$2.51 B11.76%
2025S$2.25 B-1.63%
2024S$2.28 B-20.07%
2023S$2.86 B1.79%
2022S$2.81 B15.29%
2021S$2.44 B165.93%
2020S$0.91 B1698.97%
2019S$51.02 M5.22%
2018S$48.49 M-90.61%
2017S$0.51 B-0.42%
2016S$0.51 B-76.3%
2015S$2.18 B1.31%
2014S$2.16 B-21.08%
2013S$2.73 B418.36%
2012S$0.52 B255.27%
2011S$0.14 B-12.62%
2010S$0.17 B-18.11%
2009S$0.20 B16.16%
2008S$0.17 B235.04%
2007S$53.37 M-65.24%
2006S$0.15 B-33.85%
2005S$0.23 B-4.5%
2004S$0.24 B-19.3%
2003S$0.30 B153.52%
2002S$0.11 B-73.52%
2001S$0.44 B-34.1%
2000S$0.68 B244.15%
1999S$0.19 B61.09%
1998S$0.12 B12.85%
1997S$0.10 B140.43%
1996S$45.26 M

End of Day market cap according to different sources

On Mar 17th, 2026 the market cap of Celldex Therapeutics was reported to be:

S$2.51 Billion
by Nasdaq info icon info icon
S$2.51 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Pfizer
PFE
S$199.14 B 7,811.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$248.37 B 9,766.75%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
S$136.62 B 5,327.74%๐Ÿ‡ฌ๐Ÿ‡ง UK
Titan Pharmaceuticals
TTNP
S$7.82 M-99.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Seagen
SGEN
S$55.05 B 2,087.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
S$0.18 B-92.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
S$0.54 B-78.49%๐Ÿ‡บ๐Ÿ‡ธ USA